On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase 3 clinical trial to evaluate a COVID-19 vaccine made by Janssen Pharmaceutical Companies of Johnson & Johnson.

KPWHRI was one of more than 215 clinical research sites worldwide to test the Janssen vaccine. The KPWHRI research team expected to enroll about 150 of the trial’s 60,000 volunteers.

<